|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration显示文摘 | Dixon JA Oliver SC Olson JL | | 0，，： | 1 |
| 2 | UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response 显示文摘 | Kruger EA Blagosklonny MV Dixon SC | 1998 | Invasion Metastasis1998，18，4： | 1 |
| 3 | Safety and side effects of the insulin analogues显示文摘 | Kamal AD Dixon AN Bain SC | 2006 | Expert Opin Drug Saf2006，5，1： | 1 |
| 4 | Variations in soil physical properties in a cleared forestland continuously cultivated for seven years in eastern Nsukka, Nigeria显示文摘 | Asadu CLA Obasi SC Dixon AGO | 2010 | Communications in Soil Science and Plant Analysis2010，41，2： | 1 |
| 5 | Safety and effects of the insulin analogues显示文摘 | Kamal AD Dixon AN Bain SC | 2006 | Expert Opin Drug Saf2006，5，： | 1 |
| 6 | Carboxyamido-tri- azole inhibits angiogenesis by blocking the calcium-medi- ated nitric-oxide synthase-vascular endothelial growth fac- tor pathway显示文摘 | Bauer KS Cude KJ Dixon SC | 2000 | J Pharmacol Exp Ther2000，292，1： | 1 |
| 7 | Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species- dependent显示文摘 | Bauer KS Dixon SC Figg WD | 1998 | Binchem Pharmacol1998，55，11： | 1 |
| 8 | Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent显示文摘 | Bauer KS Dixon SC Figg WD | 1998 | Biochemical Pharmacology1998，55，11： | 1 |
| 9 | Inhibition of angiogenesis by thalidomide requires metabolic activation which is species-dependent显示文摘 | Bauer KS Dixon SC Figg WD | 1998 | Biochem Pharmacol1998，55，11： | 1 |
| 10 | Inhibition of angiogenesis by thalidomide requires metabolic activation,which is species dependent显示文摘 | Dixon SC Figg WD | 1998 | Biochem Pharmacol1998，55，： | 1 |
| 11 | UCN-01, a protein Kinase C inhibitor,inhibits endothelial cell proliferation and angiogenic hypoxic response显示文摘 | Kruger Ea Blagosklonny MV Dixon SC | 1998 | Invasion Metastasis1998，18，4： | 1 |
| 12 | Inhibition of angiogenesis by thalidomide requires metabolic activation which is species-dependent 显示文摘 | Bauer KS Dixon SC Figg WD | 1998 | Biochem Pharmacol1998，55，11： | 1 |
| 13 | Obesity and survival among women with ovarian cancer:results from the Ovar- ian Cancer Association Consortium显示文摘 | Nagle CM Dixon SC Jensen A | 2015 | Br J Cancer2015，113，5： | 1 |
| 14 | Homologous pairing in vitro stimulated by the recombination hotspot chi显示文摘 | Kowalczykowski SC | 1991 | Cell1991，66，2： | 1 |
| 15 | The androgenreceptor:genetic considerations in the development and treatment of prostate cancer显示文摘 | Cude KJ Dixon SC Guo Y | 1999 | J Mol Med1999，77，： | 1 |
| 16 | Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species - dependent显示文摘 | Bauer K^iS Dixon SC Figg WK | 1998 | Biochem Pharmacol1998，55，： | 1 |
| 17 | VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration显示文摘 | Dixon JA Oliver SC Olson JL | 2009 | Expert Opin Investig Drugs2009，18，： | 1 |
| 18 | Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma 显示文摘 | Arah IN Dixon SC Horti J | 1999 | Neoplasma1999，46，2： | 1 |
| 19 | UCN-01, a protein kinase c inhibitor, inhibits endothelial cell proliferation and angogenic hypoxia response显示文摘 | Kruger EA Blagosklonny MV Dixon SC | 1998 | Invasion Metastasis1998，18，4： | 1 |
| 20 | Inhibition of Angiogenesis by thalidomide requires metabolic activition, which is species-dependent显示文摘 | Bauer KS Dixon SC and Figg WD | 1998 | Biochemical Pharmacology1998，55，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员